MacroGenics
MGNX
#9332
Rank
A$0.21 B
Marketcap
A$3.41
Share price
0.84%
Change (1 day)
34.61%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2026 (TTM): A-$0.85

According to MacroGenics's latest financial reports the company's current EPS (TTM) is A-$0.81. In 2025 the company made an earnings per share (EPS) of A-$1.68 a decrease over its 2024 EPS that were of A-$1.52.

EPS history for MacroGenics from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$0.85-49.47%
2025A-$1.6810.28%
2024A-$1.52613.33%
2023A-$0.21-92.31%
2022A-$2.77-42.14%
2021A-$4.7936.44%
2020A-$3.51-21.84%
2019A-$4.49-24.58%
2018A-$5.96675.93%
2017A-$0.77-68.05%
2016A-$2.40168.25%
2015A-$0.90-55%
2014A-$1.993400%
2013A-$0.05688-108.68%
2012A$0.6624.49%
2011A$0.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.08-233.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$42.49-5,342.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$23.06-2,945.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A-$3.70 356.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$1.80-322.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$6.46-896.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A-$3.09 280.70%๐Ÿ‡บ๐Ÿ‡ธ USA